Senior Manager, Global Neuroscience Patient Advocacy

United States

Apply with AI Apply

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Candidates should possess a Bachelor's degree and have 5+ years of experience in the pharmaceutical/biotech industry and/or patient advocacy. A working knowledge of the pharmaceutical industry, including regulatory, commercialization, and compliance requirements, is essential. Demonstrated leadership capability, excellent communication skills, the ability to work independently while managing multiple priorities with attention to detail, and a track record of responsiveness and follow-through are also required.

Responsibilities

The Senior Manager, Global Neuroscience Patient Advocacy will support the Neuroscience Advocacy team by managing stakeholders and coordinating the planning and execution of various programs and initiatives. Responsibilities include coordinating patient advocacy events, managing patient and medical congresses, supporting BMS-led advocacy events, and tracking team performance and communications. This role involves managing project deliverables according to BMS Project Management best practices, removing obstacles to project momentum, engaging project teams, and planning necessary resources for project completion. The position also requires representing BMS at external advocacy meetings, collaborating with cross-functional teams on patient-focused initiatives, and assisting with financial monitoring of the Psychiatry Advocacy team.

Skills

Patient Advocacy

Project Coordination

Stakeholder Management

Communication Skills

Attention to Detail

Teamwork

Leadership

Event Planning

Medical Conferences

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free